0001888582-21-000001.txt : 20211112 0001888582-21-000001.hdr.sgml : 20211112 20211112103018 ACCESSION NUMBER: 0001888582-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211112 DATE AS OF CHANGE: 20211112 EFFECTIVENESS DATE: 20211112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: 4e Therapeutics, Inc. CENTRAL INDEX KEY: 0001888582 IRS NUMBER: 834556016 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-420829 FILM NUMBER: 211401139 BUSINESS ADDRESS: STREET 1: 3800 N. LAMAR BLVD STREET 2: SUITE 200 CITY: AUSTIN STATE: TX ZIP: 78756 BUSINESS PHONE: 512-577-7779 MAIL ADDRESS: STREET 1: 3800 N. LAMAR BLVD STREET 2: SUITE 200 CITY: AUSTIN STATE: TX ZIP: 78756 D 1 primary_doc.xml X0708 D LIVE 0001888582 4e Therapeutics, Inc. 3800 N. LAMAR BLVD SUITE 200 AUSTIN TX TEXAS 78756 512-577-7779 DELAWARE None None Corporation true 2019 Thomas Craig Benson 3800 N. Lamar Blvd. Suite 200 Austin TX TEXAS 78756 Executive Officer Director Theodore Price 3800 N. Lamar Blvd. Suite 200 Austin TX TEXAS 78756 Director Joseph Price 3800 N. Lamar Blvd. Suite 200 Austin TX TEXAS 787656 Director Eric Price 3800 N. Lamar Blvd. Suite 200 Austin TX TEXAS 78756 Director Biotechnology Decline to Disclose 06b false 2021-10-29 false true false 0 2000020 1894992 105028 false 23 0 0 0 false 4e Therapeutics, Inc. Thomas Craig Benson Thomas Craig Benson Chief Executive Officer 2021-11-12